Your browser doesn't support javascript.
loading
Familial hypercholesterolaemia: A global call to arms.
Vallejo-Vaz, Antonio J; Kondapally Seshasai, Sreenivasa Rao; Cole, Della; Hovingh, G Kees; Kastelein, John J P; Mata, Pedro; Raal, Frederick J; Santos, Raul D; Soran, Handrean; Watts, Gerald F; Abifadel, Marianne; Aguilar-Salinas, Carlos A; Akram, Asif; Alnouri, Fahad; Alonso, Rodrigo; Al-Rasadi, Khalid; Banach, Maciej; Bogsrud, Martin P; Bourbon, Mafalda; Bruckert, Eric; Car, Josip; Corral, Pablo; Descamps, Olivier; Dieplinger, Hans; Durst, Ronen; Freiberger, Tomas; Gaspar, Isabel M; Genest, Jaques; Harada-Shiba, Mariko; Jiang, Lixin; Kayikcioglu, Meral; Lam, Carolyn S P; Latkovskis, Gustavs; Laufs, Ulrich; Liberopoulos, Evangelos; Nilsson, Lennart; Nordestgaard, Børge G; O'Donoghue, John M; Sahebkar, Amirhossein; Schunkert, Heribert; Shehab, Abdulla; Stoll, Mario; Su, Ta-Chen; Susekov, Andrey; Widén, Elisabeth; Catapano, Alberico L; Ray, Kausik K.
Afiliação
  • Vallejo-Vaz AJ; School of Public Health, Imperial College London, London, UK.
  • Kondapally Seshasai SR; Cardiovascular and Cell Sciences Research Institute, St George's University of London, London, UK.
  • Cole D; Cardiovascular and Cell Sciences Research Institute, St George's University of London, London, UK.
  • Hovingh GK; Academic Medical Centre, Amsterdam, The Netherlands.
  • Kastelein JJ; Academic Medical Centre, Amsterdam, The Netherlands.
  • Mata P; Fundación Hipercolesterolemia Familiar, Madrid, Spain.
  • Raal FJ; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Santos RD; Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.
  • Soran H; Faculty of Medical and Health Sciences, University of Manchester, Manchester, UK.
  • Watts GF; Cardiovascular Medicine, Royal Perth Hospital, University of Western Australia, Perth, Australia.
  • Abifadel M; Laboratory of Biochemistry and Molecular Therapeutics, Faculty of Pharmacy, Saint-Joseph University, Beirut, Lebanon.
  • Aguilar-Salinas CA; Instituto Nacional de Ciencias Médicas y Nutrición, Mexico City, Mexico.
  • Akram A; Global eHealth Unit, School of Public Health, Imperial College London, London, UK.
  • Alnouri F; Cardiovascular Prevention and Rehabilitation Unit, Prince Sultan Cardiac Centre Riyadh, Riyadh, Saudi Arabia.
  • Alonso R; Lipid Clinic, Department of Nutrition, Clínica Las Condes, Santiago de Chile, Chile.
  • Al-Rasadi K; Sultan Qaboos University Hospital, Muscat, Oman.
  • Banach M; Department of Hypertension, Medical University of Lodz, Lodz, Poland.
  • Bogsrud MP; National Advisory Unit on Familial Hypercholesterolemia, Norway.
  • Bourbon M; Instituto Nacional de Saúde Doutor Ricardo Jorge and BioISI - Biosystems & Integrative Sciences Institute, Universidade de Lisboa, Portugal.
  • Bruckert E; Endocrinologie métabolisme et prevention cardiovasculaire, Institut E3M et IHU cardiométabolique (ICAN), HôpitalPitiéSalpêtrière, Paris, France.
  • Car J; Global eHealth Unit, School of Public Health, Imperial College London, London, UK; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
  • Corral P; FASTA University, School of Medicine, Mar del Plata, Argentina.
  • Descamps O; Hôpital de Jolimont, Haine Saint-Paul, Belgium.
  • Dieplinger H; Austrian Atherosclerosis Society, c/o, Medical University of Innsbruck, Innsbruck, Austria.
  • Durst R; Hadassah Hebrew University Medical Center, Jerusalem, Israel.
  • Freiberger T; Centre for Cardiovascular Surgery and Transplantation Brno, and Ceitec, Masaryk University, Brno, Czech Republic.
  • Gaspar IM; Medical Genetics Department, Centro Hospitalar de Lisboa Ocidental and Genetics Laboratory, Lisbon Medical School, University of Lisbon, Portugal.
  • Genest J; McGill University, Montreal, Canada.
  • Harada-Shiba M; National Cerebral and Cardiovascular Centre Research Institute, Osaka, Japan.
  • Jiang L; National Center for Cardiovascular Diseases, Beijing, China.
  • Kayikcioglu M; Ege University Medical School, Department of Cardiology, Izmir, Turkey.
  • Lam CS; National Heart Centre Singapore and Duke-National University of Singapore, Singapore.
  • Latkovskis G; Paul Stradins Clinical University Hospital, Latvian Research Institute of Cardiology, University of Latvia, Riga, Latvia.
  • Laufs U; Universität des Saarlandes, Homburg, Germany.
  • Liberopoulos E; University of Ioannina Medical School, Ioannina, Greece.
  • Nilsson L; Department of Medical and Health Sciences, Linkoping University, Linkoping, Sweden.
  • Nordestgaard BG; Herlev and Gentofte Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
  • O'Donoghue JM; Global eHealth Unit, School of Public Health, Imperial College London, London, UK.
  • Sahebkar A; Biotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
  • Schunkert H; Deutsches Herzzentrum Munchen, Klinikan der TU Munchen, Munich Heart Alliance, Germany.
  • Shehab A; CMHS, UAE University, AlAin, United Arab Emirates.
  • Stoll M; Cardiovascular Genetic Laboratory, Cardiovascular Health Commission, Montevideo, Uruguay.
  • Su TC; Department of Internal Medicine and Cardiovascular Centre, National Taiwan University Hospital, Taipei, Taiwan.
  • Susekov A; Laboratory of Clinical Lipidology, Cardiology Research Complex, Moscow, Russia.
  • Widén E; Institute for Molecular Medicine Finland FIMM, University of Helsinki, Helsinki, Finland.
  • Catapano AL; University of Milan and Multimedica IRCCS Milan, Italy.
  • Ray KK; School of Public Health, Imperial College London, London, UK. Electronic address: k.ray@imperial.ac.uk.
Atherosclerosis ; 243(1): 257-9, 2015 Nov.
Article em En | MEDLINE | ID: mdl-26408930

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Hiperlipoproteinemia Tipo II Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Atherosclerosis Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Hiperlipoproteinemia Tipo II Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Atherosclerosis Ano de publicação: 2015 Tipo de documento: Article